# Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/retrospective-us-database-analysis-of-persistence-with-glatiramer-acetate-vs/

## Facts

| Field | Value |
| --- | --- |
| Author Names | MerriKay Oleen-Burkey,Anissa Cyhaniuk,Eric Swallow |
| Citations | 14 |
| DOI | 10.1186/1471-2377-14-11 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/1471-2377-14-11 |
| OpenAlex ID | https://openalex.org/W2047587444 |
| PMID | 24423119 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Anissa Cyhaniuk](https://scholariq.org/researchers/anissa-cyhaniuk/)

## Paper journal

- [BMC Neurology](https://scholariq.org/journals/bmc-neurology/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.